Patients with total metabolic response on FDG-PET scan should get consideration with complete response. Those with a partial response on a CT scan and a complete metabolic response on FDG-PET scan should be considered to have achieved a low risk for melanoma relapse and complete response. Patients with metastatic melanoma treated with anti-PD1 immune checkpoint

Diagnosing and tracking tumors in patients with neuroendocrine cancer is quite challenging. However, a new pharmaceutical drug was approved for use with positron emission tomography (PET) to make rare tumors visible on medical imaging. Known as Gallium-68, or NETSpot, or Gallium Dotatate, the drug is used in PET-CT imaging of neuroendocrine tumors. PET scanning helps

One low-dose chest CT scan cannot cause significant human chromosomal DNA damage to a patient. In a study to measure biologic markers of DNA damage in blood samples taken before and after a chest scan, results showed that patients who received the low-dose CT scan did not have increased numbers of DNA double-strand breaks. However,

A PET-CT scan is vital in diagnosing cancer with accuracy. A new digital PET CT scanner offers high precision cancer diagnosis. This helps oncologists develop better treatment plans for patients. The digital PET CT is the first UDR detector that helps in identifying smaller lesions in the body. It improves the reproducibility, performance, and accuracy

Amyvid imaging is used to detect the presence of amyloid-beta deposits in the brain, indicating Alzheimer’s disease. It is an excellent diagnostic tool for Alzheimer’s disease when used, keeping in mind a patient’s symptoms and age. Positive results from an Amyvid scan confirms the presence of amyloid beta deposits in the brain. Using Amyvid (florbetapir)